In This Section

Newsroom

  • October 09, 2013

    Temple University Hospital Testing Novel Investigational Treatment for Patients with Emphysema

    Temple University Hospital is participating in a multi-site, world-wide clinical trial that is testing whether implanting miniature valves in targeted regions of the lung can improve breathing, activity levels and quality of life for patients with emphysema.

  • September 23, 2013

    Arthur M. Feldman, MD, PhD, Receives Lifetime Achievement Award from the Heart Failure Society of America

    Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine and Chief Academic Officer of Temple University Health System, has received a Lifetime Achievement Award from the Heart Failure Society of America. Dr. Feldman received the award at its 17th annual meeting, held September 23 in Orlando, Florida.

  • September 05, 2013

    Youthful Stem Cells from Bone Can Heal the Heart, Raising Hope for New Heart Therapies, Temple Scientists Report

    Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center (CVRC) recently found hope in an unlikely source – stem cells in cortical, or compact, bone. In a new study, they show that when it comes to the regeneration of heart tissue, these novel bone-derived cells do a better job than the heart's own stem cells.

  • September 04, 2013

    Gil Yosipovitch, MD, Appointed Chair of the Department of Dermatology at Temple

    Gil Yosipovitch, MD, has been appointed Professor and Chair of the Department of Dermatology at Temple University School of Medicine, effective September 1, 2013. Dr. Yosipovitch most recently served as Professor of Dermatology, Neurobiology and Anatomy, Comprehensive Cancer Center, Center for Integrative Medicine and Center for Bio-Molecular Imaging at the Wake Forest School of Medicine and Wake Forest Institute for Regenerative Medicine, in Winston-Salem, North Carolina.

  • July 29, 2013

    Richard I. Fisher, MD, Named President and CEO of Fox Chase Cancer Cente

    Richard I. Fisher, MD, a leading cancer center administrator and nationally recognized hematology/oncology expert who joined Temple Health on March 1, 2013, has been appointed President and CEO of Fox Chase Cancer Center. Fisher will also hold the title of Cancer Center Director of Fox Chase, serving as the principal investigator on the Cancer Center Support Grant (CCSG) from the National Cancer Institute. He will retain the title of Senior Associate Dean for Cancer Programs at Temple University School of Medicine.
     

  • July 26, 2013

    Temple University School of Medicine Announces New Center for Metabolic Disease Research

    (Philadelphia, PA) – Temple University School of Medicine (TUSM) has launched a new Center for Metabolic Disease Research, which is committed to performing basic and clinical research identifying specific causes of metabolic diseases, and to discovering novel therapies for these diseases.

  • July 16, 2013

    Temple University Hospital Ranked Among Region's Best Hospitals by U.S. News & World Report

    Temple University Hospital has once again been included among the region’s best hospitals in U.S. News & World Report's "Best Hospitals" rankings for 2013-14. U.S. News also recognized Temple for high performance in the following specialties: Cancer; Gastroenterology and GI Surgery; Gynecology; Nephrology; Neurology and Neurosurgery; Orthopaedics; Pulmonology; and Urology. Only about 15 percent of all hospitals are recognized for high performance as among the region’s best.
     

  • May 20, 2013

    Two Temple University School of Medicine Faculty Members Selected for Prestigious NIH Posts

    (Philadelphia, PA) – Joseph Cheung, MD, PhD, Senior Associate Dean for Research and Professor of Medicine at Temple University School of Medicine, and Xiao-Feng Yang, MD, PhD, Professor of Pharmacology, Professor at the Cardiovascular Research Center and Professor at the Sol Sherry Thrombosis Research Center at Temple University School of Medicine, have been selected for prestigious posts as members of National Institutes of Health (NIH) study sections.

Pages